-
181
To construct and validate a risk score model of angiogenesis-related genes to predict the prognosis of hepatocellular carcinoma
Published 2025-02-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
182
Evaluation of Treatment Outcomes Using dNLR and GNRI in Combination Therapy With Atezolizumab and Bevacizumab for Hepatocellular Carcinoma
Published 2025-01-01Subjects: Get full text
Article -
183
The Relation between Obesity and Survival after Surgical Resection of Hepatitis C Virus-Related Hepatocellular Carcinoma
Published 2013-01-01“…We aimed to investigate the relationship between obesity and survival in hepatitis C virus-(HCV-) related hepatocellular carcinoma (HCC) patients who underwent curative surgical resection (SR). …”
Get full text
Article -
184
Comprehensive analysis of publications concerning combinations of immunotherapy and targeted therapies for hepatocellular carcinoma: a bibliometric study
Published 2025-02-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article -
185
Immune infiltration landscape and potential drug-targeted implications for hepatocellular carcinoma with ‘progression/hyper-progression’ recurrence
Published 2025-12-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
186
Gut Microbiota as Mediator and Moderator Between Hepatitis B Virus and Hepatocellular Carcinoma: A Prospective Study
Published 2024-12-01Subjects: Get full text
Article -
187
Evolution of Liver Resection for Hepatocellular Carcinoma: Change Point Analysis of Textbook Outcome over Twenty Years
Published 2024-12-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article -
188
Risk of hepatocellular carcinoma in Asian patients with primary biliary cholangitis: A nationwide and hospital cohort study
Published 2025-02-01Subjects: “…Hepatocellular carcinoma…”
Get full text
Article -
189
-
190
Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma
Published 2023-03-01Subjects: Get full text
Article -
191
Y90 Radiation Segmentectomy versus Microwave Ablation for Hepatocellular Carcinoma in Locations Suboptimal for Percutaneous Ablation
Published 2025-01-01Subjects: Get full text
Article -
192
-
193
Effect of Electric Fields on the Mechanical Mechanism of Regorafenib–VEGFR2 Interaction to Enhance Inhibition of Hepatocellular Carcinoma
Published 2025-01-01Subjects: Get full text
Article -
194
Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases—meta‐analytic assessment
Published 2019-03-01Subjects: “…hepatocellular carcinoma…”
Get full text
Article -
195
pir-hsa-216911 inhibit pyroptosis in hepatocellular carcinoma by suppressing TLR4 initiated GSDMD activation
Published 2025-01-01“…Abstract Hepatocellular carcinoma (HCC) is a global health concern, ranking as the fourth leading cause of cancer-related deaths worldwide. …”
Get full text
Article -
196
HnRNPR-mediated UPF3B mRNA splicing drives hepatocellular carcinoma metastasis
Published 2025-02-01Subjects: Get full text
Article -
197
Genetic Determinants of Immune Cells and Hepatocellular Carcinoma Risk: A Bioinformatics and Bidirectional Mendelian Randomization Study
Published 2025-01-01Subjects: Get full text
Article -
198
Construction and Characterization of Adenovirus Vectors Encoding Aspartate-β-Hydroxylase to Preliminary Application in Immunotherapy of Hepatocellular Carcinoma
Published 2018-01-01“…Dendritic cells (DCs) harboring tumor-associated antigen are supposed to be a potential immunotherapy for hepatocellular carcinoma (HCC). Aspartate-β-hydroxylase (AAH), an overexpressed tumor-associated cell surface protein, is considered as a promising biomarker and therapeutic target for HCC. …”
Get full text
Article -
199
A novel ubiquitination-related gene signature for overall survival prediction in patients with liver hepatocellular carcinoma
Published 2025-01-01Subjects: Get full text
Article -
200
Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma
Published 2025-01-01“…MASLD can progress to Metabolic Dysfunction-Associated Steatohepatitis (MASH), affecting 5.27% globally, leading to severe complications like cirrhosis and hepatocellular carcinoma. <i>Background</i>: Visceral fat distribution varies by gender, impacting MASLD development due to hormonal influences. …”
Get full text
Article